Systemic conditions and treatments as risks for implant therapy

International Journal of Oral and Maxillofacial Implants

Volumn 24, Issue , 2009, Pages 12-27

  Bornstein, Michael M ^a   Cionca, Norbert ^b   Mombelli, Andrea ^b  

^a UNIVERSITY OF BERN   (Switzerland)

^b UNIVERSITY OF GENEVA   (Switzerland)

Author keywords

Bisphosphonates; Diabetes; Implant failure; Osseointegration; Osteoporosis; Systemic disease

Indexed keywords

BISPHOSPHONIC ACID DERIVATIVE; BONE DENSITY CONSERVATION AGENT;

ACQUIRED IMMUNE DEFICIENCY SYNDROME; CARDIOVASCULAR DISEASE; CHRONIC DISEASE; CONNECTIVE TISSUE DISEASE; CROHN DISEASE; DENTAL SURGERY; DIABETES MELLITUS; DRUG CONTRAINDICATION; HUMAN; ORGAN TRANSPLANTATION; OSTEOPOROSIS; PARKINSON DISEASE; REVIEW; RISK FACTOR; SJOEGREN SYNDROME; SKULL IRRADIATION; TOOTH IMPLANTATION;

ACQUIRED IMMUNODEFICIENCY SYNDROME; BONE DENSITY CONSERVATION AGENTS; CARDIOVASCULAR DISEASES; CHRONIC DISEASE; CONNECTIVE TISSUE DISEASES; CRANIAL IRRADIATION; CROHN DISEASE; DENTAL IMPLANTATION, ENDOSSEOUS; DENTAL IMPLANTS; DENTAL RESTORATION FAILURE; DIABETES MELLITUS; DIPHOSPHONATES; HUMANS; ORGAN TRANSPLANTATION; OSTEOPOROSIS; PARKINSON DISEASE; RISK FACTORS; SJOGREN'S SYNDROME;

EID: 75549085084     PISSN: 08822786     EISSN: None     Source Type: Journal    
DOI: None     Document Type: Article

References (156)

1. Brånemark PI, Adell R, Breine U, Hansson BO, Lindström J, Ohlsson A. Intra-osseous anchorage of dental prostheses. I. Experimental studies. Scand J Plast Reconstr Surg 1969; 3: 81-100.
2. Schroeder A, Pohler O, Sutter F. Gewebsreaktion auf ein Titan-Hohlzylinderimplantat mit Titan-Spritzschichtoberfläche. Schweiz Monatsschr Zahnheilkd 1976; 86: 713-727.
3. Blanchaert RH. Implants in the medically challenged patient. Dent Clin North Am 1998; 42: 35-45.
4. Buser D, von Arx T, ten Bruggenkate CM, Weingart D. Basic surgical principles with ITI implants. Clin Oral Implants Res 2000; 11(suppl): 59-68.
5. Sugerman PB, Barber MT. Patient selection for endosseous dental implants: Oral and systemic considerations. Int J Oral Maxillofac Implants 2002; 17: 191-201.
6. Hwang D, Wang HL. Medical contraindications to implant therapy: Part I: Absolute contraindications. Implant Dent 2006; 15: 353-360.
7. Hwang D, Wang HL. Medical contraindications to implant therapy: Part II: Relative contraindications. Implant Dent 2007; 16: 13-23.
8. Chanavaz M. Patient screening and medical evaluation for implant and preprosthetic surgery. J Oral Implantol 1998; 24: 222-229.
9. American Society of Anesthesiologists. Physical Status Classification. http://www.asahq.org/clinical/physicalstatus.htm. Accessed July 28, 2009.
10. Maloney WJ, Weinberg MA. Implementation of the American Society of Anesthesiologists physical status classification system in periodontal practice. J Periodontol 2008; 79: 1124-1126.
11. Beikler T, Flemmig TF. Implants in the medically compromised patient. Crit Rev Oral Biol Med 2003; 14: 305-316.
12. van Steenberghe D, Quirynen M, Molly L, Jacobs R. Impact of systemic diseases and medication on osseointegration. Periodontol 2000 2003; 33: 163-171.
13. Wood MR, Vermilyea SG. A review of selected dental literature on evidence-based treatment planning for dental implants: Report of the Committee on Research in Fixed Prosthodontics of the Academy of Fixed Prosthodontics. J Prosthet Dent 2004; 92: 447-462.
14. Paquette DW, Brodala N, Williams RC. Risk factors for endosseous dental implant failure. Dent Clin North Am 2006; 50: 361-374.
15. Mombelli A, Cionca N. Systemic diseases affecting osseointegration therapy. Clin Oral Implants Res 2006; 17(suppl 2): 97-103.
16. Wolff K, Johnson RA, Suurmond D. Fitzpatrick’s Color Atlas & Synopsis of Clinical Dermatology, ed 5. New York: McGraw-Hill, 2006: 398-402.
17. Jensen J, Sindet-Pedersen S. Osseointegrated implants for prosthetic reconstruction in a patient with scleroderma: Report of a case. J Oral Maxillofac Surg 1990: 48: 739-741.
18. Langer Y, Cardash HS, Tal H. Use of dental implants in the treatment of patients with scleroderma: A clinical report. J Prosthet Dent 1992; 68: 873-875.
19. Patel K, Welfare R, Coonar HS. The provision of dental implants and a fixed prosthesis in the treatment of a patient with scleroderma: A clinical report. J Prosthet Dent 1998; 79: 611-612.
20. Haas SE. Implant-supported, long-span fixed partial denture for a scleroderma patient: A clinical report. J Prosthet Dent 2002; 87: 136-139.
21. Öczakir CS, Balmer S, Mericske-Stern R. Implant-prosthodontic treatment for special care patients: A case series study. Int J Prosthodont 2005; 18: 383-389.
22. Scully C, Carrozzo M. Oral mucosal disease: Lichen planus. Br J Oral Maxillofac Surg 2008; 46: 15-21.
23. Esposito SJ, Camisa C, Morgan M. Implant retained overdentures for two patients with severe lichen planus: A clinical report. J Prosthet Dent 2003; 89: 6-10.
24. Reichart PA. Oral lichen planus and dental implants. Report of 3 cases. Int J Oral Maxillofac Surg 2006; 35: 237-240.
25. Bornstein MM, Kalas L, Lemp S, Altermatt HJ, Rees TD, Buser D. Oral lichen planus and malignant transformation. A retrospective follow-up study regarding clinical and histopathologic data. Quintessence Int 2006; 37: 261-271.
26. Czerninski R, Kaplan I, Almoznino G, Maly A, Regev E. Oral squamous cell carcinoma around dental implants. Quintessence Int 2006; 37: 707-711.
27. Itthagarun A, King NM. Ectodermal dysplasia: A review and case report. Quintessence Int 1997; 28: 595-602.
28. Bergendal T, Eckerdal O, Hallonsten AL, Koch G, Kurol J, Kvint S. Osseointegrated implants in the oral habilitation of a boy with ectodermal dysplasia: A case report. Int Dent J 1991; 41: 149-156.
29. Smith RA, Vargervik K, Kearns G, Bosch C, Koumjian J. Placement of an endosseous implant in a growing child with ectodermal dysplasia. Oral Surg Oral Med Oral Pathol 1993; 75: 669-673.
30. Davarpanah M, Moon JW, Yang LR, Celletti R, Martinez H. Dental implants in the oral rehabilitation of a teenager with hypohidrotic ectodermal dysplasia: Report of a case. Int J Oral Maxillofac Implants 1997; 12: 252-258.
31. Guckes AD, McCarthy GR, Brahim J. Use of endosseous implants in a 3-year-old child with ectodermal dysplasia: Case report and 5-year follow-up. Pediatr Dent 1997; 19: 282-285.
32. Escobar V, Epker BN. Alveolar bone growth in response to endosteal implants in two patients with ectodermal dysplasia. Int J Oral Maxillofac Surg 1998; 27: 445-447.
33. Bergendal B. Prosthetic habilitation of a young patient with hypohidrotic ectodermal dysplasia and oligodontia: A case report of 20 years of treatment. Int J Prosthodont 2001; 14: 471-479.
34. Kargül B, Alcan T, Kabalay U, Atasu M. Hypohidrotic ectodermal dysplasia: Dental, clinical, genetic and dermatoglyphic findings of three cases. J Clin Pediatr Dent 2001; 26: 5-12.
35. Giray B, Akça K, Iplikçioglu H, Akça E. Two-year follow-up of a patient with oligodontia treated with implant-and toothsupported fixed partial dentures: A case report. Int J Oral Maxillofac Implants 2003; 18: 905-911.
36. Peñarrocha-Diago M, Uribe-Origone R, Rambla-Ferrer J, Guarinos-Carbó J. Fixed rehabilitation of a patient with hypohidrotic ectodermal dysplasia using zygomatic implants. Oral Surg Oral Med Oral Pathol Oral Radiol Endod 2004; 98: 161-165.
37. Kramer FJ, Baethge C, Tschernitschek H. Implants in children with ectodermal dysplasia: A case report and literature review. Clin Oral Implants Res 2007; 18: 140-146.
38. Guckes AD, Brahim, JS, McCarthy GR, Rudy SF, Cooper LF. Using endosseous dental implants for patients with ectodermal dysplasia. J Am Dent Assoc 1991; 122: 59-62.
39. Kearns G, Sharma A, Perrott D, Schmidt B, Kaban L, Vargervik K. Placement of endosseous implants in children and adolescents with hereditary ectodermal dysplasia. Oral Surg Oral Med Oral Pathol Oral Radiol Endod 1999; 88: 5-10.
40. Guckes AD, Scurria MS, King TS, McCarthy GR, Brahim J. Prospective clinical trial of dental implants in persons with ectodermal dysplasia. J Prosthet Dent 2002; 88: 21-25.
41. Sweeney IP, Ferguson, JW, Heggie AA, Lucas JO. Treatment outcomes for adolescent ectodermal dysplasia patients treated with dental implants. Int J Pediatr Dent 2005; 15: 241-248.
42. Umberto G, Maiorana C, Ghiglione V, Marzo G, Santoro F, Szabó G. Osseointegration and guided bone regeneration in ectodermal dysplasia. J Craniofac Surg 2007; 18: 1296-1304.
43. Delaleu N, Jonsson R, Koller MM. Sjögren’s syndrome. Eur J Oral Sci 2005; 113: 101-113.
44. Mathews SA, Kuien BT, Scofield RH. Oral manifestations of Sjögren’s syndrome. J Dent Res 2008; 87: 308-318.
45. Isidor F, Brondum K, Hansen HJ, Jensen J, Sindet-Pedersen S. Outcome of treatment with implant-retained dental prostheses in patients with Sjögren syndrome. Int J Oral Maxillofac Implants 1999; 14: 736-743.
46. Jackowski J, Andrich J, Käppeler H, Zöllner A, Jöhren P, Müller M. Implant-supported denture in a patient with Huntington’s disease: Interdisciplinary aspects. Spec Care Dentist 2001; 21: 15-20.
47. Ambard A, Mueninghoff L. Rehabilitation of a bulimic patient using endosteal implants. J Prosthodont 2002; 11: 176-180.
48. Lustig JP, Yanko R, Zilberman U. Use of dental implants in patients with Down syndrome: A case report. Spec Care Dentist 2002; 22: 201-204.
49. Ekfeldt A. Early experience of implant-supported prostheses in patients with neurologic disabilities. Int J Prosthodont 2005; 18: 132-138.
50. Addy L, Korszun A, Jagger RG. Dental implant treatment for patients with psychiatric disorders. Eur J Prosthodont Restor Dent 2006; 14: 90-92.
51. Jolly DE, Paulson RB, Paulson GW, Pike JA. Parkinson’s disease: A review and recommendations for dental management. Spec Care Dentist 1989; 9: 74-78.
52. Heckmann SM, Heckmann JG, Weber HP. Clinical outcomes of three Parkinson’s disease patients treated with mandibular implant overdentures. Clin Oral Implants Res 2000; 11: 566-571.
53. Kubo K, Kimura K. Implant surgery for a patient with Parkinson’s disease controlled by intravenous midazolam: A case report. Int J Oral Maxillofac Implants 2004; 19: 288-290.
54. Burgoyne RW, Tan DHS. Prolongation and quality of life for HIV-infected adults treated with highly active antiretroviral therapy (HAART): A balancing act. J Antimicrob Chemother 2008; 61: 469-473.
55. Rajnay ZW, Hochstetter RL. Immediate placement of an endosseous root-form implant in an HIV-positive patient: Report of a case. J Periodontol 1998; 69: 1167-1171.
56. Baron M, Gritsch F, Hansy AM, Haas R. Implants in an HIV-positive patient: A case report. Int J Oral Maxillofac Implants 2004; 19: 425-430.
57. Shetty K, Achong R. Dental implants in the HIV-positive patient-Case report and review of the literature. Gen Dent 2005; 53: 434-437.
58. Achong RM, Shetty K, Arribas A, Block MS. Implants in HIV-positive patients: 3 case reports. J Oral Maxillofac Surg 2006; 64: 1199-1203.
59. Strietzel FP, Rothe S, Reichart PA, Schmidt-Westhausen AM. Implant-prosthetic treatment in HIV-infected patients receiving highly active antiretroviral therapy: Report of cases. Int J Oral Maxillofac Implants 2006; 21: 951-956.
60. Stevenson GC, Riano PC, Moretti AJ, Nichols CM, Engelmeier RL, Flaitz CM. Short-term success of osseointegrated dental implants in HIV-positive individuals: A prospective study. J Contemp Dent Pract 2007; 8: 1-15.
61. Scheper HJ, Brand HS. Oral aspects of Crohn’s disease. Int Dent J 2002; 52: 163-172.
62. Steiner M, Ramp WK. Endosseous dental implants and the glucocorticoid-dependent patient. J Oral Implantol 1990; 16: 211-217.
63. van Steenberghe D, Jacobs R, Desnyder M, Maffei G, Quirynen M. The relative impact of local and endogenous patientrelated factors on implant failure up to the abutment stage. Clin Oral Implants Res 2002; 13: 617-622.
64. Alsaadi G, Quirynen M, Komárek A, van Steenberghe D. Impact of local and systemic factors on the incidence of oral implant failures, up to abutment connection. J Clin Periodontol 2007; 34: 610-617.
65. Alsaadi G, Quirynen M, Michiles K, Teughels W, Komárek A, van Steenberghe D. Impact of local and systemic factors on the incidence of failures up to abutment connection with modified surface oral implants. J Clin Periodontol 2008; 35: 51-57.
66. Tarantino A, Montagnino G, Ponticelli C. Corticosteroids in kidney transplant recipients. Safety issues and timing of discontinuation. Drug Saf 1995; 13: 145-156.
67. Dumont RJ, Ensom MH. Methods for clinical monitoring of cyclosporin in transplant patients. Clin Pharmacokinet 2000; 38: 427-447.
68. Sakakura CE, Margonar R, Holzhausen M, Nociti FH Jr, Alba RC Jr, Marcantonio E Jr. Influence of cyclosporin A therapy on bone healing around titanium implants: A histometric and biomechanic study in rabbits. J Periodontol 2003; 74: 976-981.
69. Sakakura CE, Marcantonio E Jr, Wenzel A, Scaf G. Influence of cyclosporin A on quality of bone around integrated dental implants: A radiographic study in rabbits. Clin Oral Implants Res 2006; 18: 34-39.
70. Sakakura CE, Margonar R, Holzhausen M, Nociti FH Jr, Alba RC Jr, Marcantonio E Jr. Influence of cyclosporin A therapy on bone healing around titanium implants: A histometric and biomechanic study in rabbits. J Periodontol 2007; 74: 976-981.
71. Heckmann SM, Heckmann JG, Linke JJ, Hohenberger W, Mombelli A. Implant therapy following liver transplantation: Clinical and microbiological results after 10 years. J Periodontol 2004; 75: 909-913.
72. Khadivi V, Anderson J, Zarb GA. Cardiovascular disease and treatment outcomes with osseointegration surgery. J Prosthet Dent 1999; 81: 533-536.
73. Moy PK, Medina D, Shetty V, Aghaloo TL. Dental implant failure rates and associated risk factors. Int J Oral Maxillofac Implants 2005; 20: 569-577.
74. Skamagas M, Breen TL, LeRoith D. Update on diabetes mellitus: Prevention, treatment, and association with oral disease. Oral Dis 2008; 14: 105-114.
75. Kahn BB, Flier JS. Obesity and insulin resistance. J Clin Invest 2000; 106: 473-481.
76. Taylor GW, Manz MC, Borgnakke WS. Diabetes, periodontal diseases, dental caries, and tooth loss: A review of the literature. Compend Contin Educ Dent 2004; 25: 179-190.
77. Graves DT, Liu R, Alikhani M, Al-Mashat H, Trackman PC. Diabetes-enhanced inflammation and apoptosis-Impact on periodontal pathology. J Dent Res 2006; 85: 15-21.
78. Accursi GE. Treatment outcomes with osseointegrated Brånemark implants in diabetic patients: A retrospective study [MSc thesis]. Toronto: University of Toronto, 2000.
79. Balshi SF, Wolfinger GJ, Balshi TJ. An examination of immediately loaded dental implant stability in the diabetic patient using resonance frequency analysis (RFA). Quintessence Int 2007; 38: 271-279.
80. Dowell S, Oates TW, Robinson M. Implant success in people with type 2 diabetes mellitus with varying glycemic control: A pilot study. J Am Dent Assoc 2007; 138: 355-361.
81. Smith RA, Berger R, Dodson TB. Risk factors associated with dental implants in healthy and medically compromised patients. Int J Oral Maxillofac Implants 1992; 7: 367-372.
82. Mericske-Stern R, Zarb GA. Overdentures: An alternative implant methodology for edentulous patients. Int J Prosthodont 1993; 6: 203-208.
83. Shernoff AF, Colwell JA, Bingham SF. Implants for type II diabetic patients: Interim report. VA Implants in Diabetes Study Group. Implant Dent 1994; 3: 183-185.
84. Kapur KK, Garrett NR, Hamada MO, et al. A randomized clinical trial comparing the efficacy of mandibular implant-supported overdentures and conventional dentures in diabetic patients. Part I: Methodology and clinical outcomes. J Prosthet Dent 1998; 79: 555-569.
85. Balshi TJ, Wolfinger GJ. Dental implants in the diabetic patient: A retrospective study. Implant Dent 1999; 8: 355-359.
86. Fiorellini JP, Chen PK, Nevins M, Nevins ML. A retrospective study of dental implants in diabetic patients. Int J Periodontics Restorative Dent 2000; 20: 366-373.
87. Morris HF, Ochi S, Winkler S. Implant survival in patients with type 2 diabetes: Placement to 36 months. Ann Periodontol 2000; 5: 157-165.
88. Olson JW, Shernoff AF, Tarlow JL, Colwell JA, Scheetz JP, Bingham SF. Dental endosseous implant assessments in a type 2 diabetic population: A prospective study. Int J Oral Maxillofac Implants 2000; 15: 811-818.
89. Rutar A, Lang NP, Buser D, Bürgin W, Mombelli A. Retrospective assessment of clinical and microbiological factors affecting periimplant tissue conditions. Clin Oral Implants Res 2001; 12: 189-195.
90. Abdulwassie H, Dhanrajani PJ. Diabetes mellitus and dental implants: A clinical study. Implant Dent 2002; 11: 83-86.
91. Farzad P, Andersson L, Nyberg J. Dental implant treatment in diabetic patients. Implant Dent 2002; 11: 262-267.
92. Peled M, Ardekian L, Tagger-Green N, Gutmacher Z, Machtei EE. Dental implants in patients with type 2 diabetes mellitus: A clinical study. Implant Dent 2003; 12: 116-122.
93. Ferreira SD, Silva GL, Cortelli JR, Costa JE, Costa FO. Prevalence and risk variables for peri-implant disease in Brazilian subjects. J Clin Periodontol 2006; 33: 929-935.
94. Cummings SR. Are patients with hip fractures more osteoporotic? Review of the evidence. Am J Med 1985; 78: 487-494.
95. Melton LJ 3rd, Wahner HW. Defining osteoporosis. Calcif Tissue Int 1989; 45: 263-264.
96. von Wowern N, Melsen F. Comparative bone morphometric analysis of mandibles and iliac crests. Scand J Dent Res 1979; 87: 351-357.
97. von Wowern N, Storm TL, Olgaard K. Bone mineral content by photon absorptiometry of the mandible compared with that of the forearm and the lumbar spine. Calcif Tissue Int 1988; 42: 157-161.
98. Jacobs R, Ghyselen J, Koninckx P, van Steenberghe D. Longterm bone mass evaluation of mandible and lumbar spine in a group of women receiving hormone replacement therapy. Eur J Oral Sci 1996; 104: 10-16.
99. Glaser DL, Kaplan FS. Osteoporosis. Definition and clinical presentation. Spine 1997; 22 (24, suppl): 12S-16S.
100. Fujimoto T, Niimi A, Nakai H, Ueda M. Osseointegrated implants in a patient with osteoporosis: A case report. Int J Oral Maxillofac Implants 1996; 11: 539-542.
101. Eder A, Watzek G. Treatment of a patient with severe osteoporosis and chronic polyarthritis with fixed implant-supported prosthesis: A case report. Int J Oral Maxillofac Implants 1999; 14: 587-590.
102. Degidi M, Piattelli A. Immediately loaded bar-connected implants with an anodized surface inserted in the anterior mandible in a patient treated with diphosphonates for osteoporosis: A case report with a 12-month follow-up. Clin Implant Dent Relat Res 2003; 5: 269-272.
103. Starck WJ, Epker BN. Failure of osseointegrated dental implants after diphosphonate therapy for osteoporosis: A case report. Int J Oral Maxillofac Implants 1995; 10: 74-78.
104. Mason ME, Triplett RG, Van Sickels JE, Parel SM. Mandibular fractures through endosseous cylinder implants: Report of cases and review. J Oral Maxillofac Surg 1990; 48: 311-317.
105. Friberg B, Ekestubbe A, Mellstrom D, Sennerby L. Branemark implants and osteoporosis: A clinical exploratory study. Clin Implant Dent Relat Res 2001; 3: 50-56.
106. Cranin AN. Endosteal implants in a patient with corticosteroid dependence. J Oral Implantol 1991; 17: 414-417.
107. Friberg B. Treatment with dental implants in patients with severe osteoporosis: A case report. Int J Periodontics Restorative Dent 1994; 14: 348-353.
108. von Wowern N, Gotfredsen K. Implant-supported overdentures, a prevention of bone loss in edentulous mandibles? A 5-year follow-up study. Clin Oral Implants Res 2001; 12: 19-25.
109. Minsk L, Polson AM. Dental implant outcomes in postmenopausal women undergoing hormone replacement. Compend Contin Educ Dent 1998; 19: 859-864.
110. August M, Chung K, Chang Y, Glowacki J. Influence of estrogen status on endosseous implant osseointegration. J Oral Maxillofac Surg 2001; 59: 1285-1289; discussion 1290-1291.
111. Dao TT, Anderson JD, Zarb GA. Is osteoporosis a risk factor for osseointegration of dental implants? Int J Oral Maxillofac Implants 1993; 8: 137-144.
112. Amorim MA, Takayama L, Jorgetti V, Pereira RM. Comparative study of axial and femoral bone mineral density and parameters of mandibular bone quality in patients receiving dental implants. Osteoporosis Int 2007; 18: 703-709.
113. Blomqvist JE, Alberius P, Isaksson S, Linde A, Hansson BG. Factors in implant integration failure after bone grafting: An osteometric and endocrinologic matched analysis. Int J Oral Maxillofac Surg 1996; 25: 63-68.
114. Becker W, Hujoel PP, Becker BE, Willingham H. Osteoporosis and implant failure: An exploratory case-control study. J Periodontol 2000; 71: 625-631.
115. Hubner RA, Houston SJ. Bisphosphonates’ use in metastatic bone disease. Hosp Med 2005; 66: 414-419.
116. Miller PD. Optimizing the management of postmenopausal osteoporosis with bisphosphonates: The emerging role of intermittent therapy. Clin Ther 2005; 27: 361-376.
117. Marx RE. Pamidronate (Aredia) and zoledronate (Zometa) induced avascular necrosis of the jaws: A growing epidemic. J Oral Maxillofacial Surg 2003; 61: 1115-1118.
118. Durie BGM, Katz M, Crowley J. Osteonecrosis of the jaws and bisphosphonates. N Engl J Med 2005; 353: 99-102.
119. American Association of Oral and Maxillofacial Surgeons, Advisory Task Force on Bisphosphonate-Related Osteonecrosis of the Jaws. American Association of Oral and Maxillofacial Surgeons position paper on bisphosphonate-related osteonecrosis of the jaws. J Oral Maxillofac Surg 2007; 65: 369-376.
120. Dello Russo NM, Jeffcoat MK, Marx RE, Fugazzotto P. Osteonecrosis in the jaws of patients who are using oral bisphosphonates to treat osteoporosis [JOMI current issues forum]. Int J Oral Maxillofacial Implants 2007; 22: 146-153.
121. Scully C, Madrid C, Bagan J. Dental endosseous implants in patients on bisphosphonate therapy. Implant Dent 2006; 15: 212-218.
122. Wang HL, Weber D, McCauley LK. Effect of long-term oral bisphosphonates on implant wound healing: Literature review and a case report. J Periodontol 2007; 78: 84-594.
123. Marx RE. Bisphosphonate-induced osteonecrosis of the jaws: A challenge, a responsibility, and an opportunity [editorial]. Int J Periodontics Restorative Dent 2008; 28: 5-6.
124. Otomo-Corgel J. Implants and oral bisphosphonates: Risky business? [commentary]. J Periodontol 2007; 78: 373-376.
125. Mulligan R, Sobel S. Osteoporosis: Diagnostic testing, interpretations, and correlations with oral health-Implications for dentistry. Dent Clin North Am 2005; 49: 463-484.
126. Jeffcoat MK. Safety of oral bisphosphonates: controlled studies on alveolar bone. Int J Oral Maxillofac Implants 2006; 21: 349-353.
127. Fugazzotto PA, Lightfoot WS, Jaffin R, Kumar A. Implant placement with or without simultaneous tooth extraction in patients taking oral bisphosphonates: Postoperative healing, early follow-up, and incidence of complications in two private practices. J Periodontol 2007; 78: 1664-1669.
128. Elad S, Yarom M, Khamaisi M. Comment on: Fugazzoto PA, Lightfoot WS, Jaffin R, Kumar A. Implant placement with or without simultaneous tooth extraction in patients taking oral bisphosphonates: Postoperative healing, early follow-up, and incidence of complications in two private practices. J Periodontol 2008; 79: 584-585.
129. Grant BT, Amenedo C, Freeman K, Kraut RA. Outcomes of placing dental implants in patients taking oral bisphosphonates: A review of 115 cases. J Oral Maxillofac Surg 2008; 66: 223-230.
130. Chiapasco M. Implants for patients with maxillofacial defects and following irradiation. In: Lang NP, Karring T, Lindhe J (eds). Proceedings of the 3rd European Workshop on Periodontology. Berlin: Quintessence, 1999: 557-607.
131. Granström G. Radiotherapy, osseointegration and hyperbaric oxygen therapy. Periodontol 2000 2003; 33: 145-162.
132. Colella G, Cannavale R, Pentenero M, Gandolfo S. Oral implants in radiated patients: A systematic review. Int J Oral Maxillofac Implants 2007; 22: 616-622.
133. Yerit KC, Posch M, Seemann M, et al. Implant survival in mandibles of irradiated oral cancer patients. Clin Oral Implants Res 2006; 17: 337-344.
134. Granström G. Osseointegration in irradiated cancer patients: An analysis with respect to implant failures. J Oral Maxillofac Surg 2005; 63: 579-585.
135. Schepers RH, Slagter AP, Kaanders JHAM, van den Hoogen FJA, Merkx MAW. Effect of postoperative radiotherapy on the functional result of implants placed during ablative surgery for oral cancer. Int J Oral Maxillofac Surg 2006; 35: 803-808.
136. Watzinger F, Ewers R, Henninger A, Sudasch G, Babka A, Woelfl G. Endosteal implants in the irradiated lower jaw. J Craniomaxillofac Surg 1996; 24: 237-244.
137. Esser E, Wagner W. Dental implants following radical oral cancer surgery and adjuvant radiotherapy. Int J Oral Maxillofac Implants 1997; 12: 552-557.
138. Wagner W, Esser E, Ostkamp K. Osseointegration of dental implants in patients with and without radiotherapy. Acta Oncol 1998; 37: 693-696.
139. Jisander S, Grenthe B, Alberius P. Dental implant survival in the irradiated jaw: A preliminary report. Int J Oral Maxillofac Implants 1997; 12: 643-648.
140. Larsen PE. Placement of dental implants in the irradiated mandible: A protocol involving adjunctive hyperbaric oxygen. J Oral Maxillofac Surg 1997; 55: 967-971.
141. Granström G, Tjellström A, Brånemark PI. Osseointegrated implants in irradiated bone: A case-controlled study using adjunctive hyperbaric oxygen therapy. J Oral Maxillofac Surg 1999; 57: 493-499.
142. Granström G. Placement of dental implants in irradiated bone: The case for using hyperbaric oxygen. J Oral Maxillofac Surg 2006; 64: 812-818.
143. Greenwood TW, Gilchrist AG. Hyperbaric oxygen and wound healing in post-irradiation head and neck surgery. Br J Surg 1973; 60: 394-397.
144. Mainous EG, Hart GB. Osteoradionecrosis of the mandible. Treatment with hyperbaric oxygen. Arch Otolaryngol 1975; 101: 173-177.
145. Hart GB, Mainous EG. The treatment of radiation necrosis with hyperbaric oxygen (OHP). Cancer 1976; 37: 2580-2585.
146. Marx RE, Johnson RP, Kline SN. Prevention of osteoradionecrosis: A randomized prospective clinical trial of hyperbaric oxygen versus penicillin. J Am Dent Assoc 1985; 111: 49-54.
147. Marx RE, Ehler WJ, Tayapongsak P, Pierce LW. Relationship of oxygen dose to angiogenesis induction in irradiated tissue. Am J Surg 1990; 160: 519-524.
148. Keller EE. Placement of dental implants in the irradiated mandible: A protocol without adjunctive hyperbaric oxygen. J Oral Maxillofac Surg 1997; 55: 972-980.
149. Donoff RB. Treatment of the irradiated patient with dental implants: The case against hyperbaric oxygen treatment. J Oral Maxillofac Surg 2006; 64: 819-822.
150. Esposito M, Grusovin MG, Patel S, Worthington HV, Coulthard P. Interventions for replacing missing teeth: Hyperbaric oxygen therapy for irradiated patients who require dental implants. Cochrane Database Syst Rev 2008;CD003603.
151. Schoen PJ, Raghoebar GM, Bouma J, et al. Rehabilitation of oral function in head and neck cancer patients after radiotherapy with implant-retained dentures: Effects of hyperbaric oxygen therapy. Oral Oncol 2007; 43: 379-388.
152. Feloutzis A, Lang NP, Tonetti MS, et al. IL-1 gene polymorphism and smoking as risk factors for peri-implant bone loss in a wellmaintained population. Clin Oral Implants Res 2003; 14: 10-17.
153. Gruica B, Wang HY, Lang NP, Buser D. Impact of IL-1 genotype and smoking status on the prognosis of osseointegrated implants. Clin Oral Implants Res 2004: 15: 393-400.
154. Lachmann S, Kimmerle-Müller E, Axmann D, Scheideler L, Weber H, Haas R. Associations between peri-implant crevicular fluid volume, concentrations of crevicular inflammatory mediators, and composite IL-1A-889 and IL-1b + 3954 genotype. A cross-sectional study on implant recall patients with and without clinical signs of peri-implantitis. Clin Oral Implants Res 2007; 18: 212-223.
155. Ekfeldt A, Christiansson U, Eriksson T, et al. A retrospective analysis of factors associated with multiple implant failures in maxillae. Clin Oral Implants Res 2001; 12: 462-467.
156. Mombelli A. Aging and the periodontal and peri-implant microbiota. Periodontol 2000 1998; 16: 44-52.